David Dahlgren

1.5k total citations
43 papers, 1.1k citations indexed

About

David Dahlgren is a scholar working on Oncology, Pharmaceutical Science and Pulmonary and Respiratory Medicine. According to data from OpenAlex, David Dahlgren has authored 43 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 20 papers in Pharmaceutical Science and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in David Dahlgren's work include Drug Transport and Resistance Mechanisms (22 papers), Drug Solubulity and Delivery Systems (18 papers) and Advanced Drug Delivery Systems (17 papers). David Dahlgren is often cited by papers focused on Drug Transport and Resistance Mechanisms (22 papers), Drug Solubulity and Delivery Systems (18 papers) and Advanced Drug Delivery Systems (17 papers). David Dahlgren collaborates with scholars based in Sweden, Germany and Spain. David Dahlgren's co-authors include Hans Lennernäs, Erik Sjögren, Markus Sjöblom, Carl Roos, Christer Tannergren, Per M. Hellström, Anders Lundqvist, Christian Roos, Bertil Abrahamsson and Mikael Hedeland and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Molecules.

In The Last Decade

David Dahlgren

43 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Dahlgren Sweden 20 498 435 247 160 89 43 1.1k
Kimberley A. Lentz United States 14 323 0.6× 305 0.7× 199 0.8× 33 0.2× 134 1.5× 24 963
Christer Tannergren Sweden 21 783 1.6× 696 1.6× 371 1.5× 74 0.5× 275 3.1× 35 1.7k
Timo Korjamo Finland 17 145 0.3× 373 0.9× 310 1.3× 103 0.6× 134 1.5× 29 1.0k
Miriam Verwei Netherlands 19 339 0.7× 198 0.5× 262 1.1× 27 0.2× 125 1.4× 24 1.3k
Cordula Stillhart Switzerland 17 522 1.0× 167 0.4× 132 0.5× 28 0.2× 167 1.9× 32 883
Oliver Hatley United Kingdom 16 206 0.4× 297 0.7× 206 0.8× 38 0.2× 145 1.6× 27 952
Pradeep Sharma United Kingdom 20 172 0.3× 468 1.1× 201 0.8× 62 0.4× 259 2.9× 45 1.0k
Doo‐Man Oh United States 10 301 0.6× 188 0.4× 144 0.6× 40 0.3× 68 0.8× 13 645
Walter S. Woltosz United States 7 279 0.6× 214 0.5× 109 0.4× 23 0.1× 84 0.9× 12 616
Aki T. Heikkinen Finland 18 211 0.4× 317 0.7× 215 0.9× 25 0.2× 114 1.3× 34 819

Countries citing papers authored by David Dahlgren

Since Specialization
Citations

This map shows the geographic impact of David Dahlgren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Dahlgren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Dahlgren more than expected).

Fields of papers citing papers by David Dahlgren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Dahlgren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Dahlgren. The network helps show where David Dahlgren may publish in the future.

Co-authorship network of co-authors of David Dahlgren

This figure shows the co-authorship network connecting the top 25 collaborators of David Dahlgren. A scholar is included among the top collaborators of David Dahlgren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Dahlgren. David Dahlgren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sjöblom, Markus, Ilse R. Dubbelboer, Thomas B. Borchardt, et al.. (2025). A comprehensive mechanistic investigation of factors affecting intestinal absorption and bioavailability of two PROTACs in rats. European Journal of Pharmaceutics and Biopharmaceutics. 211. 114719–114719. 3 indexed citations
2.
Dahlgren, David, et al.. (2024). Melatonin mitigates chemotherapy-induced small intestinal atrophy in rats and reduces cytotoxicity in murine intestinal organoids. PLoS ONE. 19(9). e0307414–e0307414. 1 indexed citations
3.
Borchardt, Thomas B., et al.. (2024). Development and validation of LC-MS/MS methods for the pharmacokinetic assessment of the PROTACs bavdeglutamide (ARV-110) and vepdegestrant (ARV-471). Journal of Pharmaceutical and Biomedical Analysis. 249. 116348–116348. 7 indexed citations
4.
Koziolek, Mirko, Patrick Augustijns, Rodrigo Cristofoletti, et al.. (2023). Challenges in Permeability Assessment for Oral Drug Product Development. Pharmaceutics. 15(10). 2397–2397. 12 indexed citations
5.
Dahlgren, David & Hans Lennernäs. (2023). Review on the effect of chemotherapy on the intestinal barrier: Epithelial permeability, mucus and bacterial translocation. Biomedicine & Pharmacotherapy. 162. 114644–114644. 42 indexed citations
6.
Sjöblom, Markus, et al.. (2023). Anakinra and dexamethasone treatment of idarubicin‐induced mucositis and diarrhoea in rats. Basic & Clinical Pharmacology & Toxicology. 132(6). 507–516. 7 indexed citations
7.
Dahlgren, David, Lars Agréus, Jan Stålhammar, & Per M. Hellström. (2022). Ulcerative colitis progression: a retrospective analysis of disease burden using electronic medical records. Upsala Journal of Medical Sciences. 127. 2 indexed citations
8.
Salomonsson, A.‐C., Markus Sjöblom, Per M. Hellström, et al.. (2022). The progression of doxorubicin-induced intestinal mucositis in rats. Naunyn-Schmiedeberg s Archives of Pharmacology. 396(2). 247–260. 10 indexed citations
9.
Dahlgren, David, Anette Müllertz, René Holm, et al.. (2021). Fasted and fed state human duodenal fluids: Characterization, drug solubility, and comparison to simulated fluids and with human bioavailability. European Journal of Pharmaceutics and Biopharmaceutics. 163. 240–251. 44 indexed citations
10.
Dahlgren, David, et al.. (2021). Effect of paracellular permeation enhancers on intestinal permeability of two peptide drugs, enalaprilat and hexarelin, in rats. Acta Pharmaceutica Sinica B. 11(6). 1667–1675. 24 indexed citations
11.
Dahlgren, David, Markus Sjöblom, Per M. Hellström, & Hans Lennernäs. (2021). Chemotherapeutics-Induced Intestinal Mucositis: Pathophysiology and Potential Treatment Strategies. Frontiers in Pharmacology. 12. 681417–681417. 84 indexed citations
12.
Dahlgren, David, Erik Sjögren, & Hans Lennernäs. (2020). Intestinal absorption of BCS class II drugs administered as nanoparticles: A review based on in vivo data from intestinal perfusion models. ADMET & DMPK. 8(4). 375–390. 10 indexed citations
13.
Roos, Christian, David Dahlgren, Erik Sjögren, et al.. (2019). Effects of absorption-modifying excipients on jejunal drug absorption in simulated fasted and fed luminal conditions. European Journal of Pharmaceutics and Biopharmaceutics. 142. 387–395. 14 indexed citations
14.
Dubbelboer, Ilse R., David Dahlgren, Erik Sjögren, & Hans Lennernäs. (2019). Rat intestinal drug permeability: A status report and summary of repeated determinations. European Journal of Pharmaceutics and Biopharmaceutics. 142. 364–376. 16 indexed citations
15.
Dahlgren, David, Christian Roos, Anders Lundqvist, et al.. (2019). Evaluation of drug permeability calculation based on luminal disappearance and plasma appearance in the rat single-pass intestinal perfusion model. European Journal of Pharmaceutics and Biopharmaceutics. 142. 31–37. 22 indexed citations
16.
Dahlgren, David, Christian Roos, Anders Lundqvist, et al.. (2018). Effect of absorption-modifying excipients, hypotonicity, and enteric neural activity in an in vivo model for small intestinal transport. International Journal of Pharmaceutics. 549(1-2). 239–248. 28 indexed citations
17.
Roos, Christian, David Dahlgren, Erik Sjögren, et al.. (2018). Jejunal absorption of aprepitant from nanosuspensions: Role of particle size, prandial state and mucus layer. European Journal of Pharmaceutics and Biopharmaceutics. 132. 222–230. 25 indexed citations
18.
Dahlgren, David, Christian Roos, Anders Lundqvist, et al.. (2018). Time-dependent effects on small intestinal transport by absorption-modifying excipients. European Journal of Pharmaceutics and Biopharmaceutics. 132. 19–28. 20 indexed citations
19.
Roos, Christian, Jan Westergren, David Dahlgren, Hans Lennernäs, & Erik Sjögren. (2018). Mechanistic modelling of intestinal drug absorption – The in vivo effects of nanoparticles, hydrodynamics, and colloidal structures. European Journal of Pharmaceutics and Biopharmaceutics. 133. 70–76. 21 indexed citations
20.
Dahlgren, David, Carl Roos, Erik Sjögren, & Hans Lennernäs. (2014). Direct In Vivo Human Intestinal Permeability (Peff) Determined with Different Clinical Perfusion and Intubation Methods. Journal of Pharmaceutical Sciences. 104(9). 2702–2726. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kimberley A. Lentz Breakdown of academic impact, for papers by Christer Tannergren Breakdown of academic impact, for papers by Timo Korjamo Breakdown of academic impact, for papers by Miriam Verwei Breakdown of academic impact, for papers by Cordula Stillhart Breakdown of academic impact, for papers by Oliver Hatley Breakdown of academic impact, for papers by Pradeep Sharma Breakdown of academic impact, for papers by Doo‐Man Oh Breakdown of academic impact, for papers by Walter S. Woltosz Breakdown of academic impact, for papers by Aki T. Heikkinen
Rankless by CCL
2026